Pharmacogenetic considerations in the treatment of psychiatric disorders

Falk W. Lohoff, Thomas N. Ferraro

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations


Importance of the field: Despite continued efforts to optimize pharmacological treatment for individuals with psychiatric disorders, efficacy and tolerability of medication remains highly variable. In addition to clinical heterogeneity, diagnostic uncertainty, environmental, social factors, and genetic factors have been identified as playing an important role in the interindividual differences in therapeutic and toxic drug effects. Areas covered in this review: This article describes recent developments in the field of psychiatric pharmacogenetics and focuses on antidepressant, antipsychotic, anticonvulsant, and mood-stabilizing drugs. What the reader will gain: Recent findings from pharmacogenetic clinical trials are reviewed and clinical implications are discussed. Take home message: Although current data are too sparse to allow the development of guidelines for using pharmacogenetic testing in routine clinical practice, the field of psychiatric pharmacogenetics is rapidly developing and identification of genetic biomarkers that predict therapeutic response and risk of side effects will ultimately help the practitioner to choose effective and safe treatment for patients suffering from psychiatric disorders.

Original languageEnglish (US)
Pages (from-to)423-439
Number of pages17
JournalExpert Opinion on Pharmacotherapy
Issue number3
StatePublished - Feb 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Pharmacogenetic considerations in the treatment of psychiatric disorders'. Together they form a unique fingerprint.

Cite this